Ceramide
Ceramide sind Lipide, die natürlicherweise in der äußersten Hautschicht vorkommen. Die INCI-Namen folgen einem Buchstabencode, z. B. Ceramide NP, Ceramide AP, Ceramide EOP.
30 Inhaltsstoffe
ACETOBACTER/BACILLUS/LACTOBACILLUS/SACCHAROMYCES/STREPTOCOCCUS/(APPLE/BLUEBERRY/CITRUS UNSHIU/CORNUS OFFICINALIS/CRANBERRY/EUTERPE OLERACEA/GRAPE/LYCIUM/MUME/PLUM/RASPBERRY/ROSA CANINA/SCHISANDRA/STRAWBERRY) FRUIT/(ALLIUM TUBEROSUM/CYMBOPOGON SCHOENANTHUS/LETTUCE/ROSEMARY/SPINACH/THYME/VACCINIUM MYRTILLUS) LEAF/IMPERATA CYLINDRICA ROOT/(BARLEY/PHASEOLUS ANGULARIS/PHASEOLUS RADIATUS/RICE/SOYBEAN) SEED/BROCCOLI/ERIOCEPHALUS PUNCTULATUS/MISTLETOE/ACRYLATES C10-30 ALKYL ACRYLATES CROSSPOLYMER/ALPHA-GLUCAN/BETAINE/BUTYLENE GLYCOL/EPIGALLOCATECHIN GALLATYL GLUCOSIDE/GLYCERETH-26/GLYCERIN/GLUCOSYL CERAMIDE/GLUCOSYL HESPERIDIN/HYDROLYZED HYALURONIC ACID/MALTODEXTRIN/PANTHENOL/SCLEROTIUM GUM/TROMETHAMINE/XANTHAN GUM FERMENT FILTRATE
This is a filtrate of the product obtained by the fermentation of the fruits of Citrus unshiu , Cornus officinalis , Euterpe oleracea , Fragaria ananassa, Lycium chinense, Prunus mume, Prunus salicina, Pyrus malus, Rosa canina , Rubus idaeus, Schisandra chinensis, Vaccinium angustifolium, Vaccinium macrocarpon, and Vitis vinifera; the leaves of Allium tuberosum , Cymbopogon schoenanthus , Lactuca scariola sativa, Rosmarinus officinalis, Spinacia oleracea, Thymus vulgaris, and Vaccinium myrtillus ; the roots of Imperata cylindrica ; the seeds of Glycine max, Hordeum distichon, Oryza sativa, Phaseolus angularis, and Phaseolus radiatus ; the whole plants, Brassica oleracea, Eriocephalus punctulatus and Viscum album; Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Alpha-Glucan, Betaine, Butylene Glycol, Epigallocatechin Gallate, Glycereth-26, Glycerin, Glucosyl Ceramide, Hesperidin, Hydrolyzed Hyaluronic Acid, Maltodextrin, Panthenol, Sclerotium Gum, Tromethamine and Xanthan Gum, by the microorganisms Acetobacter, Bacillus, Lactobacillus, Saccharomyces, and Streptococcus.
BIS-(CARBOXY CERAMIDE NP) POLOXAMER 407
Bis-(Carboxy Ceramide NP) Poloxamer 407 is the conjugated ceramide that conforms generally to the formula:
CERAMIDE 1
Ceramide 1 (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where n has a value ranging from 10 to 20. The INCI Name, Ceramide 1, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 1 will be retained in the retired monograph, and also published with the new name assignment, Ceramide EOP.
CERAMIDE 1 A
Ceramide 1 A (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where n has a value ranging from 10 to 20. The INCI Name, Ceramide 1 A, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 1 A will be retained in the retired monograph, and also published with the new name assignment, Ceramide EOP.
CERAMIDE 2
Ceramide 2 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 14 to 28 and n has a value ranging from 10 to 16. The INCI Name, Ceramide 2, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 2 will be retained in the retired monograph, and also published with the new name assignment as either Ceramide NS or Ceramide NG.
CERAMIDE 3
Ceramide 3 (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where m has a value ranging from 12 to 28 in which the acyl moiety may be saturated, mono-unsaturated, or di-unsaturated and n has a value ranging from 10 to 20. The INCI Name, Ceramide 3, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 3 will be retained in the retired monograph, and also published with the new name assignment, Ceramide NP.
CERAMIDE 4
Ceramide 4 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsataurated and n has a value ranging from 10 to 16. Ceramide 4 is similar to Ceramide 5, however, the acylating hydroxy acids are generally shorter in Ceramide 4 than in Ceramide 5. The INCI Name, Ceramide 4, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 4 will be retained in the retired monograph, and also published with the new name assignment, Ceramide AS.
CERAMIDE 5
Ceramide 5 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsatuarated and n has a value ranging from 10 to 16. Ceramide 5 is similar to Ceramide 4, however, the acylating hydroxy acids are generally longer in Ceramide 5 than in Ceramide 4. The INCI Name, Ceramide 5, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 5 will be retained in the retired monograph, and also published with the new name assignment, Ceramide AS.
CERAMIDE 6 II
Ceramide 6 II (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 and n has a value ranging from 12 to 20. The INCI Name, Ceramide 6 II, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 6 II will be retained in the retired monograph, and also published with the new name assignment, Ceramide AP.
CERAMIDE AG
Ceramide AG is the N-acylated sphingolipid consisting of Sphinganine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.
CERAMIDE AP
Ceramide AP, formerly known under the INCI name Ceramide 6 II, is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.
CERAMIDE AS
Ceramide AS, formerly known under either of the INCI Names, Ceramide 4 or Ceramide 5, is the N-acylated sphingolipid consisting of sphingosine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.
CERAMIDE ENP
Ceramide ENP is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to normal saturated or unsaturated fatty acid which is esterified with saturated long (C14-C26) fatty acids in the 1-O-position.
CERAMIDE EOG
Ceramide EOG is the N-acylated sphingolipid consisting of Sphinganine having the D-erythro structure linked to an omega-hydroxy acid which is esterified with a saturated or unsaturated fatty acid.
CERAMIDE EOP
Ceramide EOP, formerly known under either of the INCI Names, Ceramide 1 or Ceramide 1 A, is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to an omega-hydroxy acid which is esterified with a saturated or unsaturated fatty acid.
CERAMIDE EOS
Ceramide EOS is a synthetic N-acylated sphingolipid consisting of Sphingosine having the D-erythro structure linked to an esterified omega-hydroxy saturated or unsaturated fatty acid
CERAMIDE NG
Ceramide NG, formerly known under the INCI Name Ceramide 2, is the N-acylated sphingolipid consisting of Sphinganine having the D-erythro structure linked to a normal saturated or unsaturated fatty acid. As opposed to the broader definition for Ceramide 2 which includes sphingolipids consisting of either sphingosine or dihydrosphingosine (sphinganine), Ceramide NG is limited to sphinganine-based ceramides
CERAMIDE NG DILAURATE
Ceramide NG Dilaurate is the diester formed between Ceramide NG and Lauric Acid.
CERAMIDE NP
Ceramide NP is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to normal saturated or unsaturated fatty acid.
CERAMIDE NP OXOETHOXYDISULFIDE ACETYL ALANYL D-TETRAPEPTIDE-1 AMIDE
Ceramide NP Oxoethoxydisulfide Acetyl Alanyl D-Tetrapeptide-1 Amide is prepared by reacting Ceramide NP and oxoethoxydisulfide with the product obtained by the acetylation of the synthetic peptide consisting of Alanine and D-Tetrapeptide-1 in which the C-terminus is an amide.
CERAMIDE NP OXOETHOXYDISULFIDE ACETYL ALANYL D-TETRAPEPTIDE-1 AMIDES
Ceramide NP Oxoethoxydisulfide Acetyl Alanyl D-Tetrapeptide-1 Amides is a mixture of mono-, di-, and tri-substituted compounds prepared by reacting Ceramide NP and oxoethoxydisulfide with the product obtained by the acetylation of the synthetic peptide consisting of Alanine and D-Tetrapeptide-1 in which the C-terminus is an amide.
CERAMIDE NP STEARATE
Ceramide NP Stearate is the product obtained by the reaction of Ceramide NP and Stearic Acid.
CERAMIDE NS
Ceramide NS, formerly known under the INCI Name Ceramide 2, is the N-acylated sphingolipid consisting of sphingosine having the D-erythro structure linked to a normal saturated or unsaturated fatty acid. As opposed to the broader definition for Ceramide 2 which includes sphingolipids consisting of either sphingosine or dihydrosphingosine (sphinganine), Ceramide NS is limited to sphingosine-based ceramides.
CERAMIDE NS DILAURATE
Ceramide NS Dilaurate is the diester of Ceramide NS and lauric acid
Haben Sie die vollständige Inhaltsstoffliste?
Fügen Sie sie in die INCI-Analyse ein, um die Funktion jedes Inhaltsstoffs zu sehen.